Great West Life Assurance CO Ligand Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

A detailed history of Great West Life Assurance CO transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 23,698 shares of LGND stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,698
Previous 23,698 -0.0%
Holding current value
$2.91 Million
Previous $1.99 Million 19.04%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$68.53 - $87.91 $136,854 - $175,556
1,997 Added 9.2%
23,698 $1.99 Million
Q1 2024

May 13, 2024
BUY
$68.64 - $89.2 $71,179 - $92,500
1,037 Added 5.02%
21,701 $1.58 Million
Q4 2023

Feb 13, 2024
BUY
$49.57 - $72.63 $1,437 - $2,106
29 Added 0.14%
20,664 $1.47 Million
Q3 2023

Nov 14, 2023
BUY
$58.86 - $72.67 $32,549 - $40,186
553 Added 2.75%
20,635 $1.23 Million
Q2 2023

Aug 10, 2023
BUY
$69.53 - $79.33 $128,700 - $146,839
1,851 Added 10.15%
20,082 $1.45 Million
Q1 2023

May 12, 2023
SELL
$65.67 - $77.08 $91,478 - $107,372
-1,393 Reduced 7.1%
18,231 $1.34 Million
Q4 2022

Feb 10, 2023
SELL
$61.72 - $96.74 $58,387 - $91,516
-946 Reduced 4.6%
19,624 $1.31 Million
Q3 2022

Nov 01, 2022
BUY
$0.01 - $107.56 $205 - $2.21 Million
20,570 New
20,570 $1.77 Million
Q2 2022

Aug 09, 2022
BUY
$74.52 - $117.06 $168,266 - $264,321
2,258 Added 15.7%
16,644 $1.48 Million
Q1 2022

May 12, 2022
SELL
$94.99 - $151.56 $9,309 - $14,852
-98 Reduced 0.68%
14,386 $1.66 Million
Q4 2021

Feb 14, 2022
SELL
$127.69 - $165.85 $11,492 - $14,926
-90 Reduced 0.62%
14,484 $2.23 Million
Q3 2021

Nov 15, 2021
BUY
$102.33 - $144.73 $838,594 - $1.19 Million
8,195 Added 128.47%
14,574 $2.04 Million
Q1 2021

May 17, 2021
SELL
$99.52 - $215.83 $56,726 - $123,023
-570 Reduced 8.2%
6,379 $971,000
Q4 2020

Feb 16, 2021
SELL
$80.55 - $106.05 $57,834 - $76,143
-718 Reduced 9.36%
6,949 $691,000
Q3 2020

Nov 17, 2020
SELL
$89.56 - $126.72 $22,390 - $31,680
-250 Reduced 3.16%
7,667 $730,000
Q3 2020

Nov 13, 2020
SELL
$89.56 - $126.72 $19,076 - $26,991
-213 Reduced 2.62%
7,917 $754,000
Q2 2020

Aug 17, 2020
SELL
$68.28 - $123.65 $24,512 - $44,390
-359 Reduced 4.23%
8,130 $909,000
Q1 2020

May 14, 2020
SELL
$63.37 - $107.88 $11,026 - $18,771
-174 Reduced 2.01%
8,489 $615,000
Q4 2019

Feb 11, 2020
BUY
$96.94 - $113.59 $839,791 - $984,030
8,663 New
8,663 $903,000
Q3 2019

Oct 25, 2019
SELL
$86.25 - $120.16 $1.03 Million - $1.44 Million
-11,965 Closed
0 $0
Q2 2019

Jul 31, 2019
SELL
$107.38 - $129.34 $66,253 - $79,802
-617 Reduced 4.9%
11,965 $0
Q1 2019

May 08, 2019
SELL
$105.93 - $142.47 $24,469 - $32,910
-231 Reduced 1.8%
12,582 $1.58 Million
Q4 2018

Feb 12, 2019
SELL
$128.36 - $272.13 $1.75 Million - $3.7 Million
-13,612 Reduced 51.51%
12,813 $1.61 Million
Q3 2018

Nov 13, 2018
SELL
$211.18 - $274.49 $168,310 - $218,768
-797 Reduced 2.93%
26,425 $7.25 Million
Q2 2018

Aug 10, 2018
SELL
$150.77 - $207.98 $126,646 - $174,703
-840 Reduced 2.99%
27,222 $5.64 Million
Q1 2018

May 10, 2018
BUY
$138.63 - $182.62 $33,964 - $44,741
245 Added 0.88%
28,062 $4.64 Million
Q4 2017

Feb 09, 2018
SELL
$128.36 - $147.04 $57,505 - $65,873
-448 Reduced 1.58%
27,817 $3.81 Million
Q3 2017

Nov 09, 2017
BUY
$120.91 - $137.94 $3.42 Million - $3.9 Million
28,265
28,265 $3.81 Million

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.07B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email